- Integration of CiNii Books functions for fiscal year 2025 has completed
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- Start the collection of all publicly IRDB content
- Incorporate Research Data from KAKEN
Preliminary experience of initial and re-administration of nimustine as a new primary treatment for feline nasal lymphoma
-
- Goda Yoshimichi
- Graduate School of Medicine and Veterinary Medicine, University of Miyazaki
-
- Goto Mifumi
- Myuu Animal Clinic
-
- Hidaka Yuichi
- Graduate School of Medicine and Veterinary Medicine, University of Miyazaki Faculty of Agriculture, University of Miyazaki
-
- Inoue Yoshiyuki
- Faculty of Agriculture, University of Miyazaki
-
- Kuroda Kohei
- Faculty of Agriculture, University of Miyazaki
-
- Sato Reiichiro
- Graduate School of Medicine and Veterinary Medicine, University of Miyazaki Faculty of Agriculture, University of Miyazaki
-
- Nakatake Yuki
- The Miyazaki University Veterinary Teaching Hospital
-
- Satoh Hiroyuki
- Graduate School of Medicine and Veterinary Medicine, University of Miyazaki Faculty of Agriculture, University of Miyazaki
Bibliographic Information
- Other Title
-
- a case report
- Published
- 2024-10-30
- DOI
-
- 10.57494/jjvr.72.2_56
- Publisher
- Japanese Journal of Veterinary Research Editorial Committee
Search this article
Description
A 5-year-old spayed female domestic short haired cat presented with chronic nasal obstruction. The cat was diagnosed with B-cell nasal lymphoma based on histological examination of biopsy specimens and intracranial invasion was suspected. We initiated treatment with nimustine (ACNU), known to pass the blood–brain barrier, as the primary protocol with prednisolone, with the owner’s consent. The ACNU dose was 20–25 mg/m² (4–5-week intervals, four or six administrations, two courses). The cat remained oligosymptomatic until day 962 after the first dose and no serious adverse events were reported. The cat lived until day 1089. To our knowledge, this is the first report of long-term survival achieved using ACNU as the primary treatment in a cat with nasal lymphoma.
Journal
-
- Japanese Journal of Veterinary Research
-
Japanese Journal of Veterinary Research 72 (2), 56-64, 2024-10-30
Japanese Journal of Veterinary Research Editorial Committee
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390020530236895616
-
- ISSN
- 2758447X
- 00471917
-
- Text Lang
- en
-
- Data Source
-
- JaLC
-
- Abstract License Flag
- Disallowed
